Showing results (1-10 of 2,940) with videos related to
Sort By:
Pageof 294
Current Vascular Pharmacology|August 24, 2004
Diabetes, the renin-angiotensin system and heart diseaseHoong Sern Lim, Gregory Y H LipCurrent Pharmaceutical Design|September 28, 2007
From diabetes to metabolic syndrome: a viewpoint on an evolving conceptHoong Sern Lim, Gregory Y H LipThe Lancet. Neurology|October 20, 2007
Atrial fibrillation and stroke preventionGregory Y H Lip, Hoong Sern LimEuropace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 25, 2009
Defibrillation testing in patients with atrial fibrillationHoong Sern Lim, Gregory Y H LipExpert Opinion on Investigational Drugs|May 2, 2003
Implications of the LIFE trialSunil Nadar, Hoong Sern Lim, Gregory Y H LipCritical Care (London, England)|August 18, 2004
Clinical review: clinical management of atrial fibrillation - rate control versus rhythm controlHoong Sern Lim, Ali Hamaad, Gregory Y H LipCirculation|May 12, 2004
Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor interventionHoong Sern Lim, Andrew D Blann, Gregory Y H LipThe Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertensionHoong Sern Lim, Gregory Y H Lip, Andrew D BlannArchives of Internal Medicine|September 15, 2004
Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heartHoong Sern Lim, Robert J MacFadyen, Gregory Y H LipAtherosclerosis|April 13, 2005
Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosisHoong Sern Lim, Gregory Y H Lip, Andrew D BlannPageof 294